6 results on '"Dimopoulou D"'
Search Results
2. Association of juvenile idiopathic arthritis with PTPN22 rs2476601 is specific to females in a Greek population.
- Author
-
Goulielmos, G. N., Chiaroni-Clarke, R. C., Dimopoulou, D. G., Zervou, M. I., Trachana, M., Pratsidou-Gertsi, P., Garyfallos, A., and Ellis, J. A.
- Subjects
JUVENILE idiopathic arthritis ,SINGLE nucleotide polymorphisms ,AUTOIMMUNE diseases ,DISEASE susceptibility ,PROTEIN-tyrosine phosphatase - Abstract
Background: Juvenile idiopathic arthritis (JIA) is an autoimmune disease characterized by persistent chronic arthritis. Disease risk is believed to be influenced by both genetic and environmental factors. It is well established that the PTPN22 single nucleotide polymorphism (SNP) rs2476601 is associated with JIA susceptibility. It was recently reported in an Australian study that this association is restricted to females and is not observed in males. A significant source of inconsistency amongst the literature on autoimmune disease susceptibility genes stems from an inability to replicate genetic findings across different racial or ethnic groups. We therefore attempted to generate further evidence of the female-specific association of rs2476601 in a homogeneous Greek population. Findings: We genotyped rs2476601 in 128 Caucasian JIA patients (70.3% female) and 221 healthy controls (28.1% female) from Northern Greece. Overall, PTPN22 was associated with increased risk of JIA in this Greek sample (OR = 2.3, 95% CI 1.1 - 5.1, p = 0.038). Sex-stratified analyses showed that, once again, the risk association was restricted to females (Female: OR = 19.9, 95% CI 1.2 - 342, p = 0.0016; Male: OR = 1.1, 95% CI 0.3 - 3.1, p = 0.94) supporting the prior findings. Conclusions: Our data demonstrates that this sex-specific pattern of association is broadly applicable to different populations, and provides further impetus to undertake mechanistic studies to understand the impact of sex on PTPN22 in JIA. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease.
- Author
-
SAMONIS, G., VARDAKAS, K. Z., TANSARLI, G. S., DIMOPOULOU, D., PAPADIMITRIOU, G., KOFTERIDIS, D. P., MARAKI, S., KARANIKA, M., and FALAGAS, M. E.
- Abstract
We studied the epidemiology and microbiology of Clostridium difficile and the characteristics of patients with C. difficile infection (CDI) in Crete in three groups of hospitalized patients with diarrhoea: group 1 [positive culture and positive toxin by enzyme immunoassay (EIA)]; group 2 (positive culture, negative toxin); group 3 (negative culture, negative toxin). Patients in group 1 were designated as those with definitive CDI (20 patients for whom data was available) and matched with cases in group 2 (40 patients) and group 3 (40 patients). C. difficile grew from 6% (263/4379) of stool specimens; 14·4% of these had positive EIA, of which 3% were resistant to metronidazole. Three isolates had decreased vancomycin susceptibility. Patients in groups 1 and 2 received more antibiotics (P = 0·03) and had more infectious episodes (P = 0·03) than patients in group 3 prior to diarrhoea. Antibiotic administration for C. difficile did not differ between groups 1 and 2. Mortality was similar in all three groups (10%, 12·5% and 5%, P = 0·49). CDI frequency was low in the University Hospital of Crete and isolates were susceptible to metronidazole and vancomycin. [ABSTRACT FROM PUBLISHER]
- Published
- 2016
- Full Text
- View/download PDF
4. Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital.
- Author
-
Samonis, G., Korbila, I., Maraki, S., Michailidou, I., Vardakas, K., Kofteridis, D., Dimopoulou, D., Gkogkozotou, V., and Falagas, M.
- Subjects
ENTEROBACTERIACEAE ,COLISTIN ,TERTIARY care ,UNIVERSITY hospitals ,MEDICAL databases ,INTENSIVE care units ,MICROBIOLOGICAL laboratories ,THERAPEUTICS - Abstract
The objective of this investigation was to evaluate the association between colistin consumption and the isolation of intrinsically resistant to colistin Enterobacteriaceae (IRCE) in a university hospital in Crete, Greece. The database of the microbiological laboratory was reviewed retrospectively during 2006-2010. All positive cultures for IRCE were retrieved. We assessed the total consumption of colistin in medical, surgical, and intensive care units (ICUs). A total of 1,304 single-patient IRCE isolates were recorded. Of these, 466 (35.7%) were hospital-acquired, while 838 (64.3%) were community-acquired. Proteus spp. accounted for 72% of them, Serratia spp. for 16.6%, Morganella morganii for 8.4%, and Providencia spp. for 3%. Urine (44.8%), pus (20.4%), and lower respiratory tract specimens (12.8%) accounted for the majority of specimens. IRCE isolated during the first half (2006 to 1st semester of 2008) and second half (2nd semester of 2008 to 2010) of the study period accounted for 5.8% and 7.4% of Gram-negative isolates, respectively ( p < 0.001). Colistin consumption was not different in the two periods in the hospital, but in the ICU, it was higher in the second half of the study period ( p = 0.013). Colistin consumption was associated with the isolation of hospital-acquired IRCE ( p = 0.037); a trend was noted between colistin consumption and the isolation of IRCE in the ICU ( p = 0.057). In this study, colistin consumption was associated with the isolation of hospital-acquired IRCE. The use of colistin increased in the ICU during the study period. Prudent use of colistin is essential for the prevention of nosocomial outbreaks due to resistant IRCE. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections.
- Author
-
Samonis, G., Vardakas, K., Kofteridis, D., Dimopoulou, D., Andrianaki, A., Chatzinikolaou, I., Katsanevaki, E., Maraki, S., and Falagas, M.
- Subjects
PSEUDOMONAS diseases ,ACADEMIC medical centers ,CANCER patients ,CHI-squared test ,CONFIDENCE intervals ,DRUG resistance in microorganisms ,FISHER exact test ,LONGITUDINAL method ,MULTIVARIATE analysis ,NONPARAMETRIC statistics ,HEALTH outcome assessment ,STATISTICS ,T-test (Statistics) ,U-statistics ,LOGISTIC regression analysis ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DATA analysis software ,STATISTICAL models ,DESCRIPTIVE statistics ,ODDS ratio ,DISEASE risk factors - Abstract
Objective: To evaluate the characteristics and outcomes of cancer patients with extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. Methods: This was a retrospective cohort of P. aeruginosa infections in cancer patients in Crete, Greece. Patients were followed until discharge. Mortality, predictors of mortality and risk factors for XDR P. aeruginosa infection were studied. Results: Ninety seven episodes (89 patients) of P. aeruginosa infections (52 with bacteremia) were included in the study. In 22 cases, the infection was due to XDR isolates. All XDR isolates were susceptible to colistin and variably resistant to almost all other antibiotics. The multivariate analysis showed that the independent risk factors for XDR P. aeruginosa infection were hematologic malignancy (OR 40.7, 95 % CI 4.5-367.6) and prior fluoroquinolone use (OR 11.0, 95 % CI 2.0-60.5); lymphopenia was inversely associated with XDR infections (OR 0.16, 95 % CI 0.03-0.92). Mortality was 43 %; infection-related mortality was 24 %. Bacteremia (OR 8.47, 95 % CI 2.38-30.15), infection due to XDR isolates (OR 5.11, 95 % CI 1.15-22.62) and age (OR 1.05, 95 % CI 1.00-1.09) were independently associated with mortality. Conclusion: Mortality in cancer patients with P. aeruginosa infections was high. Infection due to XDR isolates was independently associated with mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Serratia infections in a general hospital: characteristics and outcomes.
- Author
-
Samonis, G., Vouloumanou, E., Christofaki, M., Dimopoulou, D., Maraki, S., Triantafyllou, E., Kofteridis, D., and Falagas, M.
- Subjects
SERRATIA diseases ,ANTI-infective agents ,UNIVERSITY hospitals - Abstract
We aimed to present our experience regarding infections caused by Serratia spp. in a region with relatively high antimicrobial resistance rates. We retrospectively reviewed the databases of the microbiological laboratory of the University Hospital of Heraklion, Crete (2/2004-12/2009). A total of 77 patients [67.5% men, mean age ± standard deviation (SD) = 56.9 ± 24.5 years) were identified; 37.7% were outpatients. Sixty-five (84.4%) of the 77 included patients had a Serratia marcescens isolate; the remaining 12 patients had a non-marcescens Serratia spp. The most frequently observed infections were respiratory tract infection (32.5%) and keratitis/endophthalmitis (20.8%). Seventy-three (94.9%) patients were cured. Four deaths were observed; three of them were considered as attributed to the Serratia infection. No difference was found regarding the characteristics and outcomes between patients with Serratia marcescens and non-marcescens infections. In addition, antipseudomonal penicillins and their combinations with beta-lactamase inhibitors, as well as carbapenemes, and fluoroquinolones exhibited high antimicrobial activity against both the tested Serratia marcescens and non-marcescens isolates. Our study adds useful information regarding the characteristics and outcomes of patients with Serratia infection, as well as the susceptibilities of the respective Serratia marcescens and non-marcescens isolates, in a region with relatively high levels of antimicrobial resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.